Skip to content
TirzepatideReport

Tirzepatide monograph · Evidence review

Society of You Tirzepatide Review: Cost, Named Pharmacies & Honest Verdict (2026)

An honest 2026 review of Society of You tirzepatide — two named partner pharmacies, oral and injectable options, but steep standard pricing.

Researched & written by Alan Pierce · last updated

Clinical Pharmacology Writer

On this page

Editorial pick

CoreAge Rx

$149/mo flat

Doctor-reviewed tirzepatide with one flat price and built-in human support.

Advertising disclosure · we may earn a commission at no extra cost to you.

Check availability
vs median
$120/mo below the $269 median
Market
$109–$429/mo across 396 providers
Dispensed
Compounded tirzepatide (503A)

Popular alternative

Trimi

One of the lowest compounded rates here — but only if you prepay a year up front.

$125/mo (annual prepay) · $235 monthly

Check Trimi availability

Society of You is a US telehealth brand (Society Management Group) offering compounded GLP-1 weight-loss medication filled through two named partner pharmacies — Emerald and Striker — but standard rates run steep once the intro month ends. Every fact here comes from the company's own published program.

What Society of You is

Society of You is a US telehealth brand, operated by Society Management Group, offering injectable and oral tirzepatide plus semaglutide options, filled through named partner pharmacies Emerald Pharmacy and Striker Pharmacy.

§ Society of You — Named Pharmacies, Steep Standard Rate

ItemDetail
Named pharmaciesEmerald, Striker —
Standard rate$279-$425/mo
Delivery formsInjectable and oral
Standard rates $279-$425/mo once the discounted first month ends.

What Society of You costs

Discounted first-month introductory pricing applies, but standard rates run $279-$425/month once the intro month ends — steep pricing relative to budget competitors here.

The brand-vs-compounded question

Society of You dispenses compounded semaglutide and tirzepatide, in both injectable and oral forms. Compounded tirzepatide is pharmacy-made, not itself an FDA-approved finished drug, and was not the specific product studied in the pivotal trials. See our guide to whether compounded tirzepatide is still legal in 2026 for the regulatory picture.

How the care model holds up

Society of You's real strengths: two named partner pharmacies disclosed, both injectable and oral tirzepatide options, and discounted introductory pricing. The trade-offs: standard rates run $279-$425/month once the intro month ends — a real cost step-up, service-area states aren't published on the marketing site, and support details aren't disclosed publicly. As with any GLP-1 program, confirm your standard ongoing price before assuming the intro rate applies long-term; tirzepatide carries labeled warnings for acute pancreatitis, gallbladder disease, and a boxed thyroid C-cell tumor warning — see our guides on Zepbound side effects, the gallbladder risk, and the thyroid cancer warning.

Does the drug work? (Separate from the provider)

Judge the provider on price, oversight and disclosure; judge the molecule on its trials. Tirzepatide's are strong — roughly 15–21% of body weight over 72 weeks in SURMOUNT-11, and better than semaglutide head-to-head2 — but they were run on the brand drug at FDA-approved doses. Our tirzepatide evidence guide has the full picture.

The honest verdict

Society of You's two named partner pharmacies and oral tirzepatide option are genuine positives, but the standard ongoing rate runs meaningfully higher than most budget competitors. For a provider with a lower ongoing rate and similarly named pharmacies, compare it against SnagRx or Ondra Health. See our best tirzepatide providers ranking for the full field.

Frequently asked questions

How much does tirzepatide cost through Society of You?

Standard rates run $279-$425/month after a discounted first month.

Does Society of You name its compounding pharmacies?

Yes — Emerald Pharmacy and Striker Pharmacy.

Does Society of You offer oral tirzepatide?

Yes.

References(2)

  1. Jastreboff AM, Aronne LJ, Ahmad NN, Wharton S, Connery L, Alves B, Kiyosue A, Zhang S, Liu B, Bunck MC, Stefanski A, and the SURMOUNT-1 Investigators (2022). Tirzepatide Once Weekly for the Treatment of Obesity.. New England Journal of Medicine. PMID: 35658024. https://pubmed.ncbi.nlm.nih.gov/35658024/
  2. Aronne LJ, Horn DB, le Roux CW, Ho W, Falcon BL, Bays HE, et al. (2025). Tirzepatide as Compared with Semaglutide for the Treatment of Obesity (SURMOUNT-5).. New England Journal of Medicine. PMID: 40353578. https://pubmed.ncbi.nlm.nih.gov/40353578/

About the author

Alan Pierce

Clinical Pharmacology Writer

About Tirzepatide Report · How we verify prices · This page last updated August 2026

Medical disclaimer: This content is for general educational purposes only and is not medical advice, diagnosis, or treatment. Always consult a licensed healthcare professional before starting, stopping, or changing any treatment.